MyCEI Login


Kaposi Sarcoma and KSHV Transmission in MSM and Other High Risk Groups


Published Date: 08/14/2023

Expiration Date: 07/11/2026

CE Credit: CME:1


Although we see Kaposi Sarcoma less frequently these days, it is far from gone, as we know from seroprevalence data for the causative virus, KSHV. We have had numerous talks at PRN over the past 30 years on the discovery of KSHV and the evolving therapies for the manifestations of KS. Now it is time to focus again on the silent sexual transmission of this infection and a reminder of the various manifestations of this disease in people living with HIV. In this presentation, Sheena Knights will share her recent research in the ongoing spread of KSHV in at-risk populations and health disparities that may still contribute to mortality among MSM with HIV.


Sheena M. Knights,MD

Sheena M. Knights, MD is an Assistant Professor in the Department of Internal Medicine at the University of Texas Southwestern (UTSW) Medical Center and a member of the Division of Infectious Diseases and Geographic Medicine. She is the Associate Program Director of the HIV Fellowship program.

Dr. Knights holds a bachelor's degree in chemistry from Princeton University. She earned her medical degree and completed internal medicine residency training at Baylor College of Medicine in Houston, Texas. She then completed an infectious diseases fellowship at the University of Texas Southwestern Medical Center prior to joining UTSW as faculty in 2019. Dr. Knights’s clinical interest includes a focus on HIV care. Her research interests include HIV-associated Kaposi’s sarcoma, epidemiology of KSHV, and healthcare disparities.

Learning Objectives

  • Know the 3 most common conditions caused by KSHV in patients with HIV.
  • Understand which patients are at highest risk for KSHV-related disease by reviewing KSHV epidemiology and transmission mechanisms.
  • Recognize risk factors for mortality in HIV-associated Kaposi's sarcoma.

Continuing Education Credit Information